Efficacy and Safety of Shenfu Injection for Severe Pneumonia in the Elderly: A Systematic Review and Meta-Analysis Based on Western and Eastern Medicine

• Váldodahkkit: Shihua Shi (Dahkki), Fei Wang (Dahkki), Bonan Chen (Dahkki), Jie Pan (Dahkki), Dan Luo (Dahkki), Caixia Pei (Dahkki), Demei Huang (Dahkki), Xiaomin Wang (Dahkki), Yilan Wang (Dahkki), Zherui Shen (Dahkki), Weihao Li (Dahkki), Yongcan Wu (Dahkki), Yacong He (Dahkki), Zhenxing Wang (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Frontiers Media S.A., 2022-08-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Although increasing clinical trials studying Shenfu injection (SFI) comprising panaxoside 0.8 mg/ml extracted from Panax ginseng C.A. Mey. and aconitine 0.1 mg/ml extracted from Aconitum carmichaeli Debeaux for elderly patients with severe pneumonia on biomarkers associated with COVID-19...